CD8A and neoplasm: Indeed, cancer vaccines with STING agonists were proven efficacious in different pre-clinical animal models and were shown to induce a marked programmed death ligand 1 (PD-L1) up-regulation, which was associated with tumor-infiltrating CD8(+) IFNγ(+) T cells.